X-16947022-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004726.3(REPS2):āc.161G>Cā(p.Gly54Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000151 in 859,232 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004726.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
REPS2 | NM_004726.3 | c.161G>C | p.Gly54Ala | missense_variant | 1/18 | ENST00000357277.8 | NP_004717.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
REPS2 | ENST00000357277.8 | c.161G>C | p.Gly54Ala | missense_variant | 1/18 | 1 | NM_004726.3 | ENSP00000349824.3 | ||
REPS2 | ENST00000303843.7 | c.161G>C | p.Gly54Ala | missense_variant | 1/18 | 1 | ENSP00000306033.7 | |||
REPS2 | ENST00000481792.1 | n.-48G>C | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD4 exome AF: 0.0000151 AC: 13AN: 859232Hom.: 0 Cov.: 30 AF XY: 0.00000372 AC XY: 1AN XY: 268522
GnomAD4 genome Cov.: 21
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.161G>C (p.G54A) alteration is located in exon 1 (coding exon 1) of the REPS2 gene. This alteration results from a G to C substitution at nucleotide position 161, causing the glycine (G) at amino acid position 54 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at